Company intelligence / Profile preview

FSC Laboratories

Charlotte, North Carolina, United Statesfsc-inc.com ↗

Ownership: Private
Employees: ~45
Development stage: Other

Overview

FSC Laboratories marketed three FDA-approved pediatric pharmaceutical products for infection, allergy/asthma, and GERD as well as a patented medical device (Flexichamber™) for aerosolized medication delivery. The Flexichamber received FDA clearance in 2014. The company was acquired by Flamel Technologies in February 2016.

Therapeutic areas: ImmunologyGastroenterologyInfectious Diseases
Modalities: Small moleculeMedical device
Industry: Biotech

Partnerships

No major external partnerships disclosed; prior to acquisition was affiliated with Deerfield CSF/Deerfield Management

Beyond the preview

Go deeper on FSC Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FSC Laboratories.

Explore the full profile